These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
135 related items for PubMed ID: 7826384
1. Mechanism of inhibition of protein phosphatase 1 by DARPP-32: studies with recombinant DARPP-32 and synthetic peptides. Desdouits F, Cheetham JJ, Huang HB, Kwon YG, da Cruz e Silva EF, Denefle P, Ehrlich ME, Nairn AC, Greengard P, Girault JA. Biochem Biophys Res Commun; 1995 Jan 17; 206(2):652-8. PubMed ID: 7826384 [Abstract] [Full Text] [Related]
2. Synthetic peptide analogs of DARPP-32 (Mr 32,000 dopamine- and cAMP-regulated phosphoprotein), an inhibitor of protein phosphatase-1. Phosphorylation, dephosphorylation, and inhibitory activity. Hemmings HC, Nairn AC, Elliott JI, Greengard P. J Biol Chem; 1990 Nov 25; 265(33):20369-76. PubMed ID: 2173704 [Abstract] [Full Text] [Related]
3. Characterization of the interaction between DARPP-32 and protein phosphatase 1 (PP-1): DARPP-32 peptides antagonize the interaction of PP-1 with binding proteins. Kwon YG, Huang HB, Desdouits F, Girault JA, Greengard P, Nairn AC. Proc Natl Acad Sci U S A; 1997 Apr 15; 94(8):3536-41. PubMed ID: 9108011 [Abstract] [Full Text] [Related]
4. Dopamine- and cAMP-regulated phosphoprotein DARPP-32: phosphorylation of Ser-137 by casein kinase I inhibits dephosphorylation of Thr-34 by calcineurin. Desdouits F, Siciliano JC, Greengard P, Girault JA. Proc Natl Acad Sci U S A; 1995 Mar 28; 92(7):2682-5. PubMed ID: 7708705 [Abstract] [Full Text] [Related]
5. Characterization of the inhibition of protein phosphatase-1 by DARPP-32 and inhibitor-2. Huang HB, Horiuchi A, Watanabe T, Shih SR, Tsay HJ, Li HC, Greengard P, Nairn AC. J Biol Chem; 1999 Mar 19; 274(12):7870-8. PubMed ID: 10075680 [Abstract] [Full Text] [Related]
6. Phosphorylation of DARPP-32, a dopamine- and cAMP-regulated phosphoprotein, by casein kinase II. Girault JA, Hemmings HC, Williams KR, Nairn AC, Greengard P. J Biol Chem; 1989 Dec 25; 264(36):21748-59. PubMed ID: 2557337 [Abstract] [Full Text] [Related]
7. DARPP-32, a dopamine- and adenosine 3':5'-monophosphate-regulated neuronal phosphoprotein. II. Comparison of the kinetics of phosphorylation of DARPP-32 and phosphatase inhibitor 1. Hemmings HC, Nairn AC, Greengard P. J Biol Chem; 1984 Dec 10; 259(23):14491-7. PubMed ID: 6501303 [Abstract] [Full Text] [Related]
8. Na+,K(+)-ATPase phosphorylation in the choroid plexus: synergistic regulation by serotonin/protein kinase C and isoproterenol/cAMP-PK/PP-1 pathways. Fisone G, Snyder GL, Aperia A, Greengard P. Mol Med; 1998 Apr 10; 4(4):258-65. PubMed ID: 9606178 [Abstract] [Full Text] [Related]
9. Role of calcineurin and protein phosphatase-2A in the regulation of DARPP-32 dephosphorylation in neostriatal neurons. Nishi A, Snyder GL, Nairn AC, Greengard P. J Neurochem; 1999 May 10; 72(5):2015-21. PubMed ID: 10217279 [Abstract] [Full Text] [Related]
10. DARPP-32, a dopamine-regulated neuronal phosphoprotein, is a potent inhibitor of protein phosphatase-1. Hemmings HC, Greengard P, Tung HY, Cohen P. Nature; 1999 May 10; 310(5977):503-5. PubMed ID: 6087160 [Abstract] [Full Text] [Related]
13. Dephosphorylation of Ser-137 in DARPP-32 by protein phosphatases 2A and 2C: different roles in vitro and in striatonigral neurons. Desdouits F, Siciliano JC, Nairn AC, Greengard P, Girault JA. Biochem J; 1998 Feb 15; 330 ( Pt 1)(Pt 1):211-6. PubMed ID: 9461512 [Abstract] [Full Text] [Related]
14. DARPP-32, a dopamine- and adenosine 3':5'-monophosphate-regulated neuronal phosphoprotein. I. Amino acid sequence around the phosphorylated threonine. Hemmings HC, Williams KR, Konigsberg WH, Greengard P. J Biol Chem; 1984 Dec 10; 259(23):14486-90. PubMed ID: 6501302 [Abstract] [Full Text] [Related]
15. Protein phosphatase 1 regulation by inhibitors and targeting subunits. Watanabe T, Huang HB, Horiuchi A, da Cruze Silva EF, Hsieh-Wilson L, Allen PB, Shenolikar S, Greengard P, Nairn AC. Proc Natl Acad Sci U S A; 2001 Mar 13; 98(6):3080-5. PubMed ID: 11248035 [Abstract] [Full Text] [Related]
16. Molecular determinants of nuclear protein phosphatase-1 regulation by NIPP-1. Beullens M, Van Eynde A, Vulsteke V, Connor J, Shenolikar S, Stalmans W, Bollen M. J Biol Chem; 1999 May 14; 274(20):14053-61. PubMed ID: 10318819 [Abstract] [Full Text] [Related]
17. DARPP-32, a dopamine- and cyclic AMP-regulated neuronal phosphoprotein. Primary structure and homology with protein phosphatase inhibitor-1. Williams KR, Hemmings HC, LoPresti MB, Konigsberg WH, Greengard P. J Biol Chem; 1986 Feb 05; 261(4):1890-903. PubMed ID: 3511054 [Abstract] [Full Text] [Related]
18. Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons. Bibb JA, Snyder GL, Nishi A, Yan Z, Meijer L, Fienberg AA, Tsai LH, Kwon YT, Girault JA, Czernik AJ, Huganir RL, Hemmings HC, Nairn AC, Greengard P. Nature; 1999 Dec 09; 402(6762):669-71. PubMed ID: 10604473 [Abstract] [Full Text] [Related]
19. D1-Receptor, DARPP-32, and PP-1 in the primate corpus luteum and luteinized granulosa cells: evidence for phosphorylation of DARPP-32 by dopamine and human chorionic gonadotropin. Mayerhofer A, Fritz S, Grünert R, Sanders SL, Duffy DM, Ojeda SR, Stouffer RL. J Clin Endocrinol Metab; 2000 Dec 09; 85(12):4750-7. PubMed ID: 11134138 [Abstract] [Full Text] [Related]
20. Phosphorylated Mr 32,000 dopamine- and cAMP-regulated phosphoprotein inhibits Na+,K(+)-ATPase activity in renal tubule cells. Aperia A, Fryckstedt J, Svensson L, Hemmings HC, Nairn AC, Greengard P. Proc Natl Acad Sci U S A; 1991 Apr 01; 88(7):2798-801. PubMed ID: 1849276 [Abstract] [Full Text] [Related] Page: [Next] [New Search]